71 related articles for article (PubMed ID: 18337085)
41. Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells.
Suzuki S; Tanigawara Y
Proteome Sci; 2014; 12():26. PubMed ID: 24851084
[TBL] [Abstract][Full Text] [Related]
42. Annexin A2 heterotetramer: structure and function.
Bharadwaj A; Bydoun M; Holloway R; Waisman D
Int J Mol Sci; 2013 Mar; 14(3):6259-305. PubMed ID: 23519104
[TBL] [Abstract][Full Text] [Related]
43. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
Sun Y; Gao G; Cai J; Wang Y; Qu X; He L; Liu F; Zhang Y; Lin K; Ma S; Yang X; Qian X; Zhao X
Carcinogenesis; 2013 Mar; 34(3):595-604. PubMed ID: 23188673
[TBL] [Abstract][Full Text] [Related]
44. S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.
Maletzki C; Bodammer P; Breitrück A; Kerkhoff C
Hepat Mon; 2012 Oct; 12(10 HCC):e7240. PubMed ID: 23166536
[TBL] [Abstract][Full Text] [Related]
45. The association of annexin A2 and cancers.
Zhang X; Liu S; Guo C; Zong J; Sun MZ
Clin Transl Oncol; 2012 Sep; 14(9):634-40. PubMed ID: 22855149
[TBL] [Abstract][Full Text] [Related]
46. S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells.
Suzuki S; Yamayoshi Y; Nishimuta A; Tanigawara Y
Proteome Sci; 2011 Dec; 9():76. PubMed ID: 22206547
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma.
Ogunwobi OO; Wang T; Zhang L; Liu C
J Gastroenterol Hepatol; 2012 Mar; 27(3):566-78. PubMed ID: 22097969
[TBL] [Abstract][Full Text] [Related]
48. Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.
Hoenerhoff MJ; Pandiri AR; Lahousse SA; Hong HH; Ton TV; Masinde T; Auerbach SS; Gerrish K; Bushel PR; Shockley KR; Peddada SD; Sills RC
Toxicol Pathol; 2011 Jun; 39(4):678-99. PubMed ID: 21571946
[TBL] [Abstract][Full Text] [Related]
49. Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities.
Affer M; Dao S; Liu C; Olshen AB; Mo Q; Viale A; Lambek CL; Marr TG; Clarkson BD
J Oncol; 2011; 2011():798592. PubMed ID: 21436996
[TBL] [Abstract][Full Text] [Related]
50. Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
Behboudi S; Pereira SP
World J Hepatol; 2010 Jul; 2(7):256-60. PubMed ID: 21161007
[TBL] [Abstract][Full Text] [Related]
51. Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease.
Behboudi S; Alisa A; Boswell S; Anastassiou J; Pathan AA; Williams R
Br J Cancer; 2010 Feb; 102(4):748-53. PubMed ID: 20087354
[TBL] [Abstract][Full Text] [Related]
52. Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.
Noda T; Nagano H; Takemasa I; Yoshioka S; Murakami M; Wada H; Kobayashi S; Marubashi S; Takeda Y; Dono K; Umeshita K; Matsuura N; Matsubara K; Doki Y; Mori M; Monden M
Br J Cancer; 2009 May; 100(10):1647-58. PubMed ID: 19401692
[TBL] [Abstract][Full Text] [Related]
53. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.
Takeno A; Takemasa I; Doki Y; Yamasaki M; Miyata H; Takiguchi S; Fujiwara Y; Matsubara K; Monden M
Br J Cancer; 2008 Oct; 99(8):1307-15. PubMed ID: 18827816
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of osteopontin dependent carcinogenesis.
Kapoor S
J Cancer Res Clin Oncol; 2008 Aug; 134(8):927-8. PubMed ID: 18491136
[TBL] [Abstract][Full Text] [Related]
55. Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data.
Kittaka N; Takemasa I; Takeda Y; Marubashi S; Nagano H; Umeshita K; Dono K; Matsubara K; Matsuura N; Monden M
Eur J Cancer; 2008 Apr; 44(6):885-97. PubMed ID: 18337085
[TBL] [Abstract][Full Text] [Related]
56. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
57. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
58. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
59. Functional genomics of hepatocellular carcinoma.
Thorgeirsson SS; Lee JS; Grisham JW
Hepatology; 2006 Feb; 43(2 Suppl 1):S145-50. PubMed ID: 16447291
[TBL] [Abstract][Full Text] [Related]
60. Integrative analysis of the cancer transcriptome.
Rhodes DR; Chinnaiyan AM
Nat Genet; 2005 Jun; 37 Suppl():S31-7. PubMed ID: 15920528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
